This Week We’re Talking About: Clinical Trials and Diabetes

After 2 very successful weeks on the West Coast, we now have time to focus on our Hot Topics. In anticipation of our next article in the Clinical Trials Diversity series, we’ve found a few articles we think you should read. 1. Would you want to know if you’re likely to get Alzheimer’s disease?  There […]

This Week We’re Talking About: Facebook, Merck, and Lung Cancer

Hot topics this week: Facebook is getting noticed in the clinical trial industry, Merck buys Idenix, and a new drug has been found that can lead to great news for lung cancer patients. 1.  Facebook is getting a lot of attention in clinical trials. It can have negative effects by “unblinding” a clinical trial, but […]